CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand
暂无分享,去创建一个
C. Königs | C. Giaquinto | D. Gibb | C. Dollfus | L. Ene | S. Crichton | E. Chiappini | J. Warszawski | I. Collins | R. Goodall | T. Goetghebuer | C. Thorne | L. Galli | M. Marczyńska | L. Marques | F. Prata | L. Navér | A. Volokha | A. Judd | R. Malyuta | C. Kahlert | M. Mellado | G. Jourdain | N. Klein | A. Noguera-Julian | C. Buzzoni | V. Spoulou | H. Scherpbier | Liubov Okhonskaia | T. Borkird | P. Attavinijtrakarn | M. I. G. Tomé
[1] C. Giaquinto,et al. Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV‐1 infection 2015: optimizing health in preparation for adult life , 2015, HIV medicine.
[2] R. Callard,et al. Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial , 2017, Front. Immunol..
[3] R. Callard,et al. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy , 2017, The Pediatric infectious disease journal.
[4] R. Ferrand,et al. Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges , 2016, Tropical medicine & international health : TM & IH.
[5] C. Rouzioux,et al. Interruption of cART in Clinical Practice Is Associated With an Increase in the Long-Term Risk of Subsequent Immunosuppression in HIV-1-Infected Children , 2014, The Pediatric infectious disease journal.
[6] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[7] S. Madhi,et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial , 2013, The Lancet.
[8] R. Callard,et al. Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study , 2013, PLoS medicine.
[9] J. Ananworanich,et al. Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions , 2013, AIDS.
[10] R. Callard,et al. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. , 2012, The Journal of infectious diseases.
[11] Brian C. Zanoni,et al. Sex differences in HIV RNA level and CD4 cell percentage during childhood. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] S. Spector,et al. CD4+ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy Interruption , 2011, Journal of acquired immune deficiency syndromes.
[13] J. Ananworanich,et al. Response to planned treatment interruptions in HIV infection varies across childhood , 2010, AIDS.
[14] A. d’Arminio Monforte,et al. Response to combination antiretroviral therapy: variation by age , 2008, AIDS.
[15] Akihiko Saitoh,et al. Clinical Outcomes After an Unstructured Treatment Interruption in Children and Adolescents With Perinatally Acquired HIV Infection , 2008, Pediatrics.
[16] Dart Trial Team. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl , 2008 .
[17] A. Monforte,et al. Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study , 2007, Journal of acquired immune deficiency syndromes.
[18] J. Ragnaud,et al. Intermittent antiretroviral therapy in patients with controlled HIV infection. , 2007, AIDS.
[19] J Darbyshire,et al. CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.
[20] Matthias Cavassini,et al. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial , 2006, The Lancet.
[21] Roger Salamon,et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial , 2006, The Lancet.
[22] N. Klein,et al. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. , 2002, The Journal of infectious diseases.
[23] W. Boehler,et al. Almer, A , 2001 .
[24] M. Leal,et al. CD4+ and CD8+ T lymphocyte regeneration after anti‐retroviral therapy in HIV‐1‐infected children and adult patients , 2000, Clinical and experimental immunology.
[25] C. Giaquinto,et al. Features of children perinatally infected with HIV-1 surviving longer than 5 years Italian Register for HIV Infection in Children , 1994, The Lancet.
[26] O. Commissioner. King's College Hospital , 1857, British medical journal.